Med LifeBSE:M +0.53%90 Operating Margin % is 5.15% as of Mar. 2026, which is 8% below its 10-year median of 5.59. GuruFocus rates BSE:M with a GF Score™ of 90/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Med Life ranks better than 51.35% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Med Life's Operating Income for the
three
months ended in Mar. 2026 was lei44 Mil. Med Life's Revenue for the
three
months ended in Mar. 2026 was lei853 Mil. Therefore, Med Life's Operating Margin % for the quarter that ended in Mar. 2026 was 5.15%.
Warning Sign:
Med Life SA operating margin has been in a 5-year decline. The average rate of decline per year is -10.4%.
The historical rank and industry rank for Med Life's Operating Margin % or its related term are showing as below:
BSE:M'
s Operating Margin % Range Over the Past 10 Years
Min: 3.69 Med: 5.59 Max: 12.41
Current: 5.15
BSE:M's Operating Margin % is ranked better than 51.35% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs BSE:M: 5.15
Med Life's 5-Year Average Operating Margin % Growth Rate was -10.40% per year.
Med Life's Operating Income for the
three
months ended in Mar. 2026 was lei44 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was lei126 Mil.
Med Life (BSE:M) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Med Life Operating Margin % Related Terms
Med Life Operating Margin % Historical Data
* Premium members only.
The historical data trend for Med Life's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSE:M vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, Med Life's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Med Life's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Med Life's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (BSE:M) has a Operating Margin % of 5.15% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Med Life and its competitors. This is near median its historical median of 5.59. Over the past decade, Med Life's Operating Margin % has ranged from 3.69 to 12.41. According to the industry distribution chart, Med Life ranks #325 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 48.7%.
Is Med Life's Operating Margin % too high?
Med Life's current Operating Margin % of 5.15% is near median its 10-year median of 5.59. Over the past 10 years, this metric has ranged from a low of 3.69 to a high of 12.41. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Med Life's value of 5.15% is 6.3% above this industry median. Based on the distribution chart, Med Life ranks #325 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Med Life has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #325 out of 668 companies for Operating Margin %. This puts Med Life in the upper half of its industry. The industry median Operating Margin % is 4.85. Med Life's value of 5.15% is 6.3% above this benchmark. Historically, Med Life's own Operating Margin % has ranged from 3.69 to 12.41 over the past decade. While the company's 10-year median is 5.59 vs. the industry median of 4.85, Med Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Operating Margin % of 5.15% is 6.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Operating Margin % is 5.15%, which is near median its own 10-year median of 5.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.82, compared to a current price of lei11.36 — trading 45.3% above its estimated fair value. The current Operating Margin % is 5.15%, which is near median its 10-year median of 5.59 and 6.3% above the Healthcare Providers & Services industry median of 4.85. Med Life's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Med Life (BSE:M), the current Operating Margin % is 5.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.36 is trading 45.3% above its estimated GF Value™ of lei7.82.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
Operating Margin %: 5.15% (near median its 10-year median of 5.59)
GF Value™: lei7.82 vs. price of lei11.36 (45.3% above fair value)
Industry Position: 6.3% above the Healthcare Providers & Services median (#325 of 668)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
90GF Score
Get the complete analysis for BSE:M
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
